Oxford Cannabinoid Technologies Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 12

Employees

  • Stock Symbol
  • OCTHF

Stock Symbol

Oxford Cannabinoid Technologies General Information

Description

Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The company uses a drug development that includes proprietary cannabinoid derivatives, natural phytocannabinoids (pCBs), and in-licensed compounds. Its primary market focus is the pain market, and OCT initially aims to develop a portfolio of four drug candidates for approval as licensed pain medicines.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Prama House
  • 267 Banbury Road
  • Oxford OX2 7HT
  • England, United Kingdom
+44 020
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Pharmaceuticals
Stock Exchange
PINX
Vertical(s)
Corporate Office
  • Prama House
  • 267 Banbury Road
  • Oxford OX2 7HT
  • England, United Kingdom
+44 020

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Cannabinoid Technologies Stock Performance

As of 08-May-2024, Oxford Cannabinoid Technologies’s current market cap is $2.11M with 1.09B shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.04 $2.11M 1.09B 29.1K

Oxford Cannabinoid Technologies Financials Summary

As of 31-Oct-2023, Oxford Cannabinoid Technologies has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 31-Oct-2023 FY 2023 30-Apr-2023 FY 2022 30-Apr-2022 FY 2021 31-May-2021
EV (1,857)
Revenue 0 0 0
EBITDA (6,025) (8,400) 21 (4,237)
Net Income (5,227) (7,135) (4,299)
Total Assets 3,394 5,650 9,148 21,569
Total Debt 0 0 0 247
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Oxford Cannabinoid Technologies Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Oxford Cannabinoid Technologies‘s full profile, request access.

Request a free trial

Oxford Cannabinoid Technologies Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Oxford Cannabinoid Technologies Holdings PLC is a pharmaceutical company engaged in cannabinoid drug development. The co
Drug Discovery
Oxford, United Kingdom
12 As of 2023

Vancouver, Canada
 

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oxford Cannabinoid Technologies Competitors (4)

One of Oxford Cannabinoid Technologies’s 4 competitors is InMed Pharmaceuticals, a Corporation company based in Vancouver, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InMed Pharmaceuticals Corporation Vancouver, Canada
AXIM Biotechnologies Corporation New York, NY
CV Sciences Corporation San Diego, CA
Zynerba Pharmaceuticals Formerly VC-backed Plymouth, PA
To view Oxford Cannabinoid Technologies’s complete competitors history, request access »

Oxford Cannabinoid Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford Cannabinoid Technologies Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Oxford Cannabinoid Technologies‘s full profile, request access.

Request a free trial

Oxford Cannabinoid Technologies FAQs

  • When was Oxford Cannabinoid Technologies founded?

    Oxford Cannabinoid Technologies was founded in 2017.

  • Where is Oxford Cannabinoid Technologies headquartered?

    Oxford Cannabinoid Technologies is headquartered in Oxford, United Kingdom.

  • What is the size of Oxford Cannabinoid Technologies?

    Oxford Cannabinoid Technologies has 12 total employees.

  • What industry is Oxford Cannabinoid Technologies in?

    Oxford Cannabinoid Technologies’s primary industry is Drug Discovery.

  • Is Oxford Cannabinoid Technologies a private or public company?

    Oxford Cannabinoid Technologies is a Public company.

  • What is Oxford Cannabinoid Technologies’s stock symbol?

    The ticker symbol for Oxford Cannabinoid Technologies is OCTHF.

  • What is the current market cap of Oxford Cannabinoid Technologies?

    The current market capitalization of Oxford Cannabinoid Technologies is $2.11M.

  • Who are Oxford Cannabinoid Technologies’s competitors?

    InMed Pharmaceuticals, AXIM Biotechnologies, CV Sciences, and Zynerba Pharmaceuticals are competitors of Oxford Cannabinoid Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »